

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.31163072 |
| 2 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.31163072 |
| 3 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.46578520 |
| 4 | positive regulation of gamma-delta T cell activation (GO:0046645) | 4.51622457 |
| 5 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 4.50462684 |
| 6 | protein retention in ER lumen (GO:0006621) | 4.32107115 |
| 7 | urea metabolic process (GO:0019627) | 4.18429597 |
| 8 | urea cycle (GO:0000050) | 4.12293973 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.97809964 |
| 10 | ribosomal small subunit assembly (GO:0000028) | 3.95141098 |
| 11 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.91407206 |
| 12 | nitrogen cycle metabolic process (GO:0071941) | 3.86836140 |
| 13 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 3.79801975 |
| 14 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 3.78126662 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 3.66820408 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 3.66820408 |
| 17 | regulation of gamma-delta T cell activation (GO:0046643) | 3.56964570 |
| 18 | positive regulation of B cell differentiation (GO:0045579) | 3.53967581 |
| 19 | negative regulation of fibrinolysis (GO:0051918) | 3.53838417 |
| 20 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 3.53683488 |
| 21 | actin nucleation (GO:0045010) | 3.51209298 |
| 22 | complement activation, alternative pathway (GO:0006957) | 3.49470748 |
| 23 | negative regulation of phagocytosis (GO:0050765) | 3.45346696 |
| 24 | pentose-phosphate shunt (GO:0006098) | 3.45183960 |
| 25 | hemidesmosome assembly (GO:0031581) | 3.44888439 |
| 26 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 3.43973843 |
| 27 | peptidyl-glutamic acid carboxylation (GO:0017187) | 3.41347727 |
| 28 | protein carboxylation (GO:0018214) | 3.41347727 |
| 29 | protein localization to endosome (GO:0036010) | 3.39981028 |
| 30 | desmosome organization (GO:0002934) | 3.29531201 |
| 31 | UDP-N-acetylglucosamine metabolic process (GO:0006047) | 3.29343449 |
| 32 | defense response to fungus (GO:0050832) | 3.25471406 |
| 33 | viral transcription (GO:0019083) | 3.24849974 |
| 34 | positive regulation of triglyceride lipase activity (GO:0061365) | 3.21720362 |
| 35 | positive regulation of lipoprotein lipase activity (GO:0051006) | 3.21720362 |
| 36 | cellular glucuronidation (GO:0052695) | 3.18391302 |
| 37 | hepatocyte apoptotic process (GO:0097284) | 3.18129470 |
| 38 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.16143656 |
| 39 | regulation of fibrinolysis (GO:0051917) | 3.14992682 |
| 40 | GDP-mannose metabolic process (GO:0019673) | 3.12996249 |
| 41 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 3.12336778 |
| 42 | regulation of protein activation cascade (GO:2000257) | 3.11378886 |
| 43 | translational termination (GO:0006415) | 3.09424272 |
| 44 | NADH metabolic process (GO:0006734) | 3.09153150 |
| 45 | epoxygenase P450 pathway (GO:0019373) | 3.06645412 |
| 46 | regulation of plasminogen activation (GO:0010755) | 3.05888719 |
| 47 | protein targeting to ER (GO:0045047) | 3.02588571 |
| 48 | fibrinolysis (GO:0042730) | 3.02559967 |
| 49 | regulation of B cell differentiation (GO:0045577) | 3.01671198 |
| 50 | leukocyte aggregation (GO:0070486) | 3.01544767 |
| 51 | cotranslational protein targeting to membrane (GO:0006613) | 3.00733251 |
| 52 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.00649510 |
| 53 | NADPH regeneration (GO:0006740) | 2.99518845 |
| 54 | regulation of B cell receptor signaling pathway (GO:0050855) | 2.99215882 |
| 55 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 2.98924035 |
| 56 | glucuronate metabolic process (GO:0019585) | 2.98809182 |
| 57 | uronic acid metabolic process (GO:0006063) | 2.98809182 |
| 58 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.98341039 |
| 59 | L-phenylalanine metabolic process (GO:0006558) | 2.97411990 |
| 60 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 2.97411990 |
| 61 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.96944218 |
| 62 | hormone catabolic process (GO:0042447) | 2.96048092 |
| 63 | DNA deamination (GO:0045006) | 2.96046266 |
| 64 | basement membrane organization (GO:0071711) | 2.95974464 |
| 65 | regulation of complement activation (GO:0030449) | 2.95387010 |
| 66 | skin morphogenesis (GO:0043589) | 2.94115410 |
| 67 | immunoglobulin mediated immune response (GO:0016064) | 2.93513627 |
| 68 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.92443719 |
| 69 | fatty acid beta-oxidation using acyl-CoA oxidase (GO:0033540) | 2.90515284 |
| 70 | response to fungus (GO:0009620) | 2.88322897 |
| 71 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 2.87799018 |
| 72 | protein localization to endoplasmic reticulum (GO:0070972) | 2.85985716 |
| 73 | regulation of cholesterol homeostasis (GO:2000188) | 2.84689999 |
| 74 | positive regulation of pseudopodium assembly (GO:0031274) | 2.82186511 |
| 75 | proline biosynthetic process (GO:0006561) | 2.82115351 |
| 76 | virion attachment to host cell (GO:0019062) | 2.81837459 |
| 77 | adhesion of symbiont to host cell (GO:0044650) | 2.81837459 |
| 78 | adhesion of symbiont to host (GO:0044406) | 2.81117116 |
| 79 | translational elongation (GO:0006414) | 2.80738672 |
| 80 | positive regulation of lamellipodium assembly (GO:0010592) | 2.80000714 |
| 81 | regulation of extracellular matrix disassembly (GO:0010715) | 2.78192234 |
| 82 | positive regulation of extracellular matrix organization (GO:1903055) | 2.77331165 |
| 83 | acute-phase response (GO:0006953) | 2.76155503 |
| 84 | cell-substrate junction assembly (GO:0007044) | 2.76095062 |
| 85 | complement activation, classical pathway (GO:0006958) | 2.75400308 |
| 86 | ethanol oxidation (GO:0006069) | 2.73066303 |
| 87 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 2.72276024 |
| 88 | B cell receptor signaling pathway (GO:0050853) | 2.71385079 |
| 89 | mannose metabolic process (GO:0006013) | 2.70923595 |
| 90 | proline metabolic process (GO:0006560) | 2.70068030 |
| 91 | primary alcohol catabolic process (GO:0034310) | 2.69829395 |
| 92 | maintenance of gastrointestinal epithelium (GO:0030277) | 2.69675569 |
| 93 | positive regulation of lipid catabolic process (GO:0050996) | 2.69237242 |
| 94 | cell adhesion mediated by integrin (GO:0033627) | 2.68144630 |
| 95 | regulation of respiratory burst (GO:0060263) | 2.66590825 |
| 96 | glucose 6-phosphate metabolic process (GO:0051156) | 2.64215385 |
| 97 | megakaryocyte development (GO:0035855) | 2.63531820 |
| 98 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.63291771 |
| 99 | doxorubicin metabolic process (GO:0044598) | 2.62632488 |
| 100 | daunorubicin metabolic process (GO:0044597) | 2.62632488 |
| 101 | polyketide metabolic process (GO:0030638) | 2.62632488 |
| 102 | positive thymic T cell selection (GO:0045059) | 2.62501016 |
| 103 | regulation of early endosome to late endosome transport (GO:2000641) | 2.62100429 |
| 104 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.61684532 |
| 105 | complement activation (GO:0006956) | 2.61289856 |
| 106 | amyloid precursor protein catabolic process (GO:0042987) | 2.60992995 |
| 107 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.60716435 |
| 108 | negative thymic T cell selection (GO:0045060) | 2.58527366 |
| 109 | negative T cell selection (GO:0043383) | 2.57830622 |
| 110 | regulation of triglyceride catabolic process (GO:0010896) | 2.57682259 |
| 111 | negative regulation of lipopolysaccharide-mediated signaling pathway (GO:0031665) | 2.56993178 |
| 112 | ethanol metabolic process (GO:0006067) | 2.56625413 |
| 113 | mature B cell differentiation involved in immune response (GO:0002313) | 2.56104733 |
| 114 | response to interferon-beta (GO:0035456) | 2.55802958 |
| 115 | stress fiber assembly (GO:0043149) | 2.54688532 |
| 116 | NIK/NF-kappaB signaling (GO:0038061) | 2.53617212 |
| 117 | mast cell activation (GO:0045576) | 2.53437202 |
| 118 | epithelial cell-cell adhesion (GO:0090136) | 2.53084290 |
| 119 | T cell apoptotic process (GO:0070231) | 2.52575099 |
| 120 | glutamine family amino acid biosynthetic process (GO:0009084) | 2.52554152 |
| 121 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 2.52266046 |
| 122 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 2.52020458 |
| 123 | negative regulation of cell killing (GO:0031342) | 2.52020458 |
| 124 | B cell mediated immunity (GO:0019724) | 2.51812638 |
| 125 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.51642964 |
| 126 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 2.51486665 |
| 127 | angiotensin maturation (GO:0002003) | 2.50131144 |
| 128 | viral life cycle (GO:0019058) | 2.49162733 |
| 129 | pinocytosis (GO:0006907) | 2.48561805 |
| 130 | very-low-density lipoprotein particle assembly (GO:0034379) | 2.48319091 |
| 131 | negative regulation of hemostasis (GO:1900047) | 2.47919337 |
| 132 | negative regulation of blood coagulation (GO:0030195) | 2.47919337 |
| 133 | regulation of metalloenzyme activity (GO:0048552) | 2.47664002 |
| 134 | T cell homeostasis (GO:0043029) | 2.47207208 |
| 135 | definitive hemopoiesis (GO:0060216) | 2.46604233 |
| 136 | regulation of T cell receptor signaling pathway (GO:0050856) | 2.46544526 |
| 137 | response to laminar fluid shear stress (GO:0034616) | 2.46237949 |
| 138 | COPII vesicle coating (GO:0048208) | 2.46043225 |
| 139 | signal peptide processing (GO:0006465) | 2.45774866 |
| 140 | purine nucleotide salvage (GO:0032261) | 2.45521250 |
| 141 | response to type I interferon (GO:0034340) | 2.45474453 |
| 142 | protein activation cascade (GO:0072376) | 2.45396474 |
| 143 | response to protozoan (GO:0001562) | 2.44922274 |
| 144 | positive regulation of lamellipodium organization (GO:1902745) | 2.44028724 |
| 145 | mucosal-associated lymphoid tissue development (GO:0048537) | 2.43615490 |
| 146 | Peyers patch development (GO:0048541) | 2.43615490 |
| 147 | endodermal cell differentiation (GO:0035987) | 2.43586180 |
| 148 | folic acid-containing compound biosynthetic process (GO:0009396) | 2.43544529 |
| 149 | regulation of erythrocyte differentiation (GO:0045646) | 2.43203301 |
| 150 | cellular response to type I interferon (GO:0071357) | 2.40944239 |
| 151 | type I interferon signaling pathway (GO:0060337) | 2.40944239 |
| 152 | myeloid dendritic cell activation (GO:0001773) | 2.40709488 |
| 153 | hypotonic response (GO:0006971) | 2.40647589 |
| 154 | regulation of pseudopodium assembly (GO:0031272) | 2.39975275 |
| 155 | regulation of necroptotic process (GO:0060544) | 2.39935817 |
| 156 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.39556812 |
| 157 | fat-soluble vitamin biosynthetic process (GO:0042362) | 2.39232318 |
| 158 | negative regulation of coagulation (GO:0050819) | 2.39189836 |
| 159 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.38867628 |
| 160 | hyaluronan catabolic process (GO:0030214) | 2.38556147 |
| 161 | apoptotic cell clearance (GO:0043277) | 2.38468372 |
| 162 | killing of cells in other organism involved in symbiotic interaction (GO:0051883) | 2.37988021 |
| 163 | disruption of cells of other organism involved in symbiotic interaction (GO:0051818) | 2.37988021 |
| 164 | respiratory burst (GO:0045730) | 2.37877615 |
| 165 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.37610333 |
| 166 | membrane protein ectodomain proteolysis (GO:0006509) | 2.36508414 |
| 167 | lymph node development (GO:0048535) | 2.36315587 |
| 168 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 2.36235045 |
| 169 | interferon-gamma production (GO:0032609) | 2.35756180 |
| 170 | negative regulation of fatty acid transport (GO:2000192) | 2.35634479 |
| 171 | drug metabolic process (GO:0017144) | 2.35625028 |
| 172 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.35548556 |
| 173 | L-phenylalanine catabolic process (GO:0006559) | 2.35548556 |
| 174 | alpha-linolenic acid metabolic process (GO:0036109) | 2.34709345 |
| 175 | focal adhesion assembly (GO:0048041) | 2.34461586 |
| 176 | cell-substrate adherens junction assembly (GO:0007045) | 2.34461586 |
| 177 | activation of signaling protein activity involved in unfolded protein response (GO:0006987) | 2.34237205 |
| 178 | regulation of extracellular matrix organization (GO:1903053) | 2.34109137 |
| 179 | fucose catabolic process (GO:0019317) | 2.33563519 |
| 180 | L-fucose metabolic process (GO:0042354) | 2.33563519 |
| 181 | L-fucose catabolic process (GO:0042355) | 2.33563519 |
| 182 | cellular response to zinc ion (GO:0071294) | 2.33269535 |
| 183 | cellular protein complex disassembly (GO:0043624) | 2.31832049 |
| 184 | cellular response to interleukin-4 (GO:0071353) | 2.31663699 |
| 185 | chaperone mediated protein folding requiring cofactor (GO:0051085) | 2.30487610 |
| 186 | hexose catabolic process (GO:0019320) | 2.30079403 |
| 187 | leukotriene biosynthetic process (GO:0019370) | 2.29127673 |
| 188 | lymphocyte apoptotic process (GO:0070227) | 2.28546752 |
| 189 | mature B cell differentiation (GO:0002335) | 2.28529629 |
| 190 | barbed-end actin filament capping (GO:0051016) | 2.28152807 |
| 191 | purine-containing compound salvage (GO:0043101) | 2.27834152 |
| 192 | leukocyte cell-cell adhesion (GO:0007159) | 2.27681843 |
| 193 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.27253363 |
| 194 | intestinal absorption (GO:0050892) | 2.27074242 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 3.97909270 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 3.23417817 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.13166144 |
| 4 | MYC_22102868_ChIP-Seq_BL_Human | 2.96383208 |
| 5 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.95204926 |
| 6 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.86227405 |
| 7 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.85168734 |
| 8 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.79856870 |
| 9 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.54114174 |
| 10 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.48116352 |
| 11 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.47834594 |
| 12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.45419137 |
| 13 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.44980437 |
| 14 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.41547191 |
| 15 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.40339157 |
| 16 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 2.35204800 |
| 17 | RACK7_27058665_Chip-Seq_MCF-7_Human | 2.33925796 |
| 18 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.29068485 |
| 19 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.18736040 |
| 20 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.13976829 |
| 21 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 2.13417200 |
| 22 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.10955583 |
| 23 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 2.06420654 |
| 24 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.98477817 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.98156264 |
| 26 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 1.97973534 |
| 27 | * MAF_26560356_Chip-Seq_TH1_Human | 1.97716918 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.96001758 |
| 29 | * NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.95752425 |
| 30 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.95514573 |
| 31 | MYB_26560356_Chip-Seq_TH2_Human | 1.93676914 |
| 32 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.91088692 |
| 33 | UTX_26944678_Chip-Seq_JUKART_Human | 1.89742139 |
| 34 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.89673538 |
| 35 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.88263727 |
| 36 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.87257445 |
| 37 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.86538385 |
| 38 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.85389890 |
| 39 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.82392481 |
| 40 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.80789474 |
| 41 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.78404544 |
| 42 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 1.77586778 |
| 43 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.75260714 |
| 44 | MYB_26560356_Chip-Seq_TH1_Human | 1.74498064 |
| 45 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.72466024 |
| 46 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.71094593 |
| 47 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.69882923 |
| 48 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 1.69048374 |
| 49 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.67906595 |
| 50 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.67247655 |
| 51 | * E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66708328 |
| 52 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.65176177 |
| 53 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.63837948 |
| 54 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.63722499 |
| 55 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.63264084 |
| 56 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.63153752 |
| 57 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 1.57188724 |
| 58 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.55831678 |
| 59 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.55404238 |
| 60 | GATA1_22025678_ChIP-Seq_K562_Human | 1.54599619 |
| 61 | * UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.53967157 |
| 62 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.53011830 |
| 63 | TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.52288880 |
| 64 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.50250753 |
| 65 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.50009486 |
| 66 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.46857513 |
| 67 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.43954723 |
| 68 | SOX2_27498859_Chip-Seq_STOMACH_Mouse | 1.43536634 |
| 69 | ATF3_27146783_Chip-Seq_COLON_Human | 1.43402572 |
| 70 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.43197887 |
| 71 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 1.41894925 |
| 72 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.41426466 |
| 73 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.41309033 |
| 74 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.38565779 |
| 75 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.37968757 |
| 76 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.37251000 |
| 77 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 1.36462029 |
| 78 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.36369603 |
| 79 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.36084245 |
| 80 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.35202133 |
| 81 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.34188724 |
| 82 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.32643584 |
| 83 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32362909 |
| 84 | KDM2B_26808549_Chip-Seq_K562_Human | 1.31952549 |
| 85 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.31700886 |
| 86 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.31531767 |
| 87 | * SPI1_23127762_ChIP-Seq_K562_Human | 1.31098234 |
| 88 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.30879648 |
| 89 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.30608658 |
| 90 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.29729213 |
| 91 | * MAF_26560356_Chip-Seq_TH2_Human | 1.29229415 |
| 92 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.29111139 |
| 93 | * ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.28855910 |
| 94 | * TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.28461069 |
| 95 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.28124311 |
| 96 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 1.26981032 |
| 97 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.26847711 |
| 98 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.25866961 |
| 99 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 1.25858490 |
| 100 | MYC_18358816_ChIP-ChIP_MESCs_Mouse | 1.25413042 |
| 101 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.25106147 |
| 102 | * SMC4_20622854_ChIP-Seq_HELA_Human | 1.24723453 |
| 103 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.24603881 |
| 104 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.24519278 |
| 105 | * SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 1.24175743 |
| 106 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.24031161 |
| 107 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.24013761 |
| 108 | ZFP281_18358816_ChIP-ChIP_MESCs_Mouse | 1.23375681 |
| 109 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.22466825 |
| 110 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.22026089 |
| 111 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.21677821 |
| 112 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.20931753 |
| 113 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.20793951 |
| 114 | TCFAP2C_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.19877802 |
| 115 | * P68_20966046_ChIP-Seq_HELA_Human | 1.19424894 |
| 116 | * GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.18990287 |
| 117 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.17992896 |
| 118 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.17672342 |
| 119 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.17315751 |
| 120 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.17228681 |
| 121 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.16669914 |
| 122 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.14953474 |
| 123 | TP53_22127205_ChIP-Seq_IMR90_Human | 1.14746636 |
| 124 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.13940724 |
| 125 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.12608322 |
| 126 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 1.12510728 |
| 127 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 1.11875942 |
| 128 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 1.11875942 |
| 129 | * RUNX1_27514584_Chip-Seq_MCF-7_Human | 1.11840240 |
| 130 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.10534304 |
| 131 | * GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.10337062 |
| 132 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 1.09312788 |
| 133 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.08574715 |
| 134 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.08435311 |
| 135 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.07777867 |
| 136 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.07425418 |
| 137 | * CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.07129982 |
| 138 | CREB1_26743006_Chip-Seq_LNCaP_Human | 1.07008477 |
| 139 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.06896765 |
| 140 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.06893266 |
| 141 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 1.05758876 |
| 142 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 1.05069477 |
| 143 | GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04945395 |
| 144 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.04782043 |
| 145 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.04709513 |
| 146 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.04240340 |
| 147 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 1.03939433 |
| 148 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03556053 |
| 149 | * GATA6_25053715_ChIP-Seq_YYC3_Human | 1.02947842 |
| 150 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.02633014 |
| 151 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.01891604 |
| 152 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.01171096 |
| 153 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.00116681 |
| 154 | GABP_19822575_ChIP-Seq_HepG2_Human | 0.99468070 |
| 155 | KLF4_18555785_ChIP-Seq_MESCs_Mouse | 0.99309949 |
| 156 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 0.99304255 |
| 157 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 0.99112116 |
| 158 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 0.98869900 |
| 159 | * SREBP2_21459322_ChIP-Seq_LIVER_Mouse | 0.98852074 |
| 160 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.98092796 |
| 161 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.98081538 |
| 162 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.96388670 |
| 163 | PU_27001747_Chip-Seq_BMDM_Mouse | 0.96224152 |
| 164 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.95193893 |
| 165 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.95037343 |
| 166 | * BCL6_27268052_Chip-Seq_Bcells_Human | 0.94330279 |
| 167 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.94124791 |
| 168 | JARID1B-DAIN_22020125_ChIP-Seq_ESCs_Mouse | 0.94018711 |
| 169 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 0.93941300 |
| 170 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 0.93808343 |
| 171 | * MYC_19030024_ChIP-ChIP_MESCs_Mouse | 0.93654090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0008438_abnormal_cutaneous_collagen | 3.50459199 |
| 2 | MP0001835_abnormal_antigen_presentation | 2.84075693 |
| 3 | MP0003300_gastrointestinal_ulcer | 2.66938510 |
| 4 | MP0003436_decreased_susceptibility_to | 2.64006672 |
| 5 | MP0003866_abnormal_defecation | 2.54535550 |
| 6 | MP0002396_abnormal_hematopoietic_system | 2.53831703 |
| 7 | MP0001873_stomach_inflammation | 2.47404911 |
| 8 | MP0000685_abnormal_immune_system | 2.47074853 |
| 9 | MP0005451_abnormal_body_composition | 2.41079649 |
| 10 | MP0010155_abnormal_intestine_physiology | 2.35088151 |
| 11 | MP0009785_altered_susceptibility_to | 2.34755390 |
| 12 | MP0003763_abnormal_thymus_physiology | 2.31897926 |
| 13 | MP0005464_abnormal_platelet_physiology | 2.29479050 |
| 14 | MP0000490_abnormal_crypts_of | 2.25315919 |
| 15 | MP0001800_abnormal_humoral_immune | 2.22915357 |
| 16 | MP0005025_abnormal_response_to | 2.20853966 |
| 17 | MP0005671_abnormal_response_to | 2.15907447 |
| 18 | MP0006054_spinal_hemorrhage | 2.15628474 |
| 19 | MP0003303_peritoneal_inflammation | 2.09052757 |
| 20 | MP0002452_abnormal_antigen_presenting | 2.00682831 |
| 21 | * MP0002420_abnormal_adaptive_immunity | 1.98977715 |
| 22 | MP0001790_abnormal_immune_system | 1.98608309 |
| 23 | MP0005387_immune_system_phenotype | 1.98608309 |
| 24 | MP0003693_abnormal_embryo_hatching | 1.98585643 |
| 25 | * MP0001819_abnormal_immune_cell | 1.96878127 |
| 26 | * MP0002398_abnormal_bone_marrow | 1.96344230 |
| 27 | MP0005000_abnormal_immune_tolerance | 1.96145095 |
| 28 | MP0000465_gastrointestinal_hemorrhage | 1.95315708 |
| 29 | MP0002166_altered_tumor_susceptibility | 1.95158924 |
| 30 | MP0004272_abnormal_basement_membrane | 1.94384431 |
| 31 | MP0002419_abnormal_innate_immunity | 1.93999589 |
| 32 | MP0002723_abnormal_immune_serum | 1.92514702 |
| 33 | MP0010352_gastrointestinal_tract_polyps | 1.91561440 |
| 34 | MP0009333_abnormal_splenocyte_physiolog | 1.91205929 |
| 35 | MP0004264_abnormal_extraembryonic_tissu | 1.88078062 |
| 36 | MP0004858_abnormal_nervous_system | 1.87283574 |
| 37 | MP0009840_abnormal_foam_cell | 1.86943201 |
| 38 | MP0008260_abnormal_autophagy | 1.86157106 |
| 39 | MP0001849_ear_inflammation | 1.85977800 |
| 40 | MP0005360_urolithiasis | 1.85568110 |
| 41 | MP0005257_abnormal_intraocular_pressure | 1.84625508 |
| 42 | MP0002796_impaired_skin_barrier | 1.80732688 |
| 43 | MP0001666_abnormal_nutrient_absorption | 1.77104795 |
| 44 | MP0003279_aneurysm | 1.73805380 |
| 45 | * MP0000716_abnormal_immune_system | 1.72016520 |
| 46 | MP0001845_abnormal_inflammatory_respons | 1.68623534 |
| 47 | MP0000689_abnormal_spleen_morphology | 1.68364857 |
| 48 | MP0002405_respiratory_system_inflammati | 1.68157895 |
| 49 | MP0004808_abnormal_hematopoietic_stem | 1.67818432 |
| 50 | * MP0002722_abnormal_immune_system | 1.67548840 |
| 51 | MP0002148_abnormal_hypersensitivity_rea | 1.66872600 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.66432038 |
| 53 | MP0005397_hematopoietic_system_phenotyp | 1.66432038 |
| 54 | MP0002138_abnormal_hepatobiliary_system | 1.65923681 |
| 55 | MP0001958_emphysema | 1.63783735 |
| 56 | MP0005409_darkened_coat_color | 1.63027397 |
| 57 | MP0003191_abnormal_cellular_cholesterol | 1.62179941 |
| 58 | MP0003183_abnormal_peptide_metabolism | 1.61915392 |
| 59 | MP0004947_skin_inflammation | 1.60472339 |
| 60 | * MP0002429_abnormal_blood_cell | 1.58364636 |
| 61 | MP0005365_abnormal_bile_salt | 1.58312321 |
| 62 | MP0010234_abnormal_vibrissa_follicle | 1.58179229 |
| 63 | MP0003724_increased_susceptibility_to | 1.53369464 |
| 64 | MP0003656_abnormal_erythrocyte_physiolo | 1.50426842 |
| 65 | MP0002006_tumorigenesis | 1.48028806 |
| 66 | MP0003172_abnormal_lysosome_physiology | 1.47565629 |
| 67 | MP0003091_abnormal_cell_migration | 1.45984328 |
| 68 | MP0001663_abnormal_digestive_system | 1.44796752 |
| 69 | MP0001853_heart_inflammation | 1.38566295 |
| 70 | MP0009384_cardiac_valve_regurgitation | 1.38514739 |
| 71 | MP0008469_abnormal_protein_level | 1.36409604 |
| 72 | MP0003453_abnormal_keratinocyte_physiol | 1.35385092 |
| 73 | MP0005058_abnormal_lysosome_morphology | 1.32923976 |
| 74 | MP0002060_abnormal_skin_morphology | 1.32124993 |
| 75 | MP0005275_abnormal_skin_tensile | 1.32058022 |
| 76 | MP0005501_abnormal_skin_physiology | 1.30591581 |
| 77 | MP0001533_abnormal_skeleton_physiology | 1.27765007 |
| 78 | MP0006082_CNS_inflammation | 1.27550467 |
| 79 | MP0005174_abnormal_tail_pigmentation | 1.25672645 |
| 80 | MP0000678_abnormal_parathyroid_gland | 1.25170144 |
| 81 | MP0002877_abnormal_melanocyte_morpholog | 1.24306116 |
| 82 | MP0000858_altered_metastatic_potential | 1.23892231 |
| 83 | MP0000703_abnormal_thymus_morphology | 1.23448786 |
| 84 | MP0005670_abnormal_white_adipose | 1.21560374 |
| 85 | MP0005085_abnormal_gallbladder_physiolo | 1.21256226 |
| 86 | MP0000477_abnormal_intestine_morphology | 1.19793695 |
| 87 | MP0005310_abnormal_salivary_gland | 1.19147063 |
| 88 | MP0000604_amyloidosis | 1.17685136 |
| 89 | MP0003329_amyloid_beta_deposits | 1.16238996 |
| 90 | MP0000609_abnormal_liver_physiology | 1.15943716 |
| 91 | MP0002139_abnormal_hepatobiliary_system | 1.15942425 |
| 92 | MP0000467_abnormal_esophagus_morphology | 1.14965546 |
| 93 | MP0005083_abnormal_biliary_tract | 1.10414021 |
| 94 | MP0001542_abnormal_bone_strength | 1.07539327 |
| 95 | MP0008875_abnormal_xenobiotic_pharmacok | 1.05875923 |
| 96 | MP0002019_abnormal_tumor_incidence | 1.05763209 |
| 97 | MP0003252_abnormal_bile_duct | 1.05028604 |
| 98 | MP0010329_abnormal_lipoprotein_level | 1.04295463 |
| 99 | MP0005381_digestive/alimentary_phenotyp | 1.04118270 |
| 100 | MP0004019_abnormal_vitamin_homeostasis | 1.04020775 |
| 101 | MP0009278_abnormal_bone_marrow | 1.03818099 |
| 102 | MP0010368_abnormal_lymphatic_system | 1.03124599 |
| 103 | MP0002896_abnormal_bone_mineralization | 1.02750336 |
| 104 | MP0003806_abnormal_nucleotide_metabolis | 1.01459856 |
| 105 | MP0000767_abnormal_smooth_muscle | 1.00897621 |
| 106 | MP0002089_abnormal_postnatal_growth/wei | 0.99827647 |
| 107 | MP0001216_abnormal_epidermal_layer | 0.99739438 |
| 108 | MP0004185_abnormal_adipocyte_glucose | 0.99013048 |
| 109 | MP0009643_abnormal_urine_homeostasis | 0.98599992 |
| 110 | MP0005220_abnormal_exocrine_pancreas | 0.98420820 |
| 111 | MP0004957_abnormal_blastocyst_morpholog | 0.97035123 |
| 112 | MP0005666_abnormal_adipose_tissue | 0.96797927 |
| 113 | MP0003868_abnormal_feces_composition | 0.96342917 |
| 114 | MP0003566_abnormal_cell_adhesion | 0.94613268 |
| 115 | MP0003448_altered_tumor_morphology | 0.93385578 |
| 116 | MP0002098_abnormal_vibrissa_morphology | 0.93204796 |
| 117 | MP0000003_abnormal_adipose_tissue | 0.93088697 |
| 118 | MP0005164_abnormal_response_to | 0.92532750 |
| 119 | MP0005375_adipose_tissue_phenotype | 0.92506519 |
| 120 | MP0000462_abnormal_digestive_system | 0.91698031 |
| 121 | MP0003075_altered_response_to | 0.91578741 |
| 122 | MP0005075_abnormal_melanosome_morpholog | 0.91362775 |
| 123 | MP0009053_abnormal_anal_canal | 0.90450763 |
| 124 | MP0002998_abnormal_bone_remodeling | 0.90197607 |
| 125 | MP0002933_joint_inflammation | 0.89983942 |
| 126 | MP0005319_abnormal_enzyme/_coenzyme | 0.88566188 |
| 127 | MP0002118_abnormal_lipid_homeostasis | 0.88204159 |
| 128 | MP0000598_abnormal_liver_morphology | 0.87639503 |
| 129 | MP0004782_abnormal_surfactant_physiolog | 0.87205749 |
| 130 | MP0005166_decreased_susceptibility_to | 0.85497536 |
| 131 | MP0005023_abnormal_wound_healing | 0.85213516 |
| 132 | MP0000538_abnormal_urinary_bladder | 0.83898965 |
| 133 | MP0001243_abnormal_dermal_layer | 0.83596029 |
| 134 | MP0001881_abnormal_mammary_gland | 0.82742130 |
| 135 | MP0005623_abnormal_meninges_morphology | 0.82110274 |
| 136 | MP0002971_abnormal_brown_adipose | 0.81532693 |
| 137 | MP0005390_skeleton_phenotype | 0.81058185 |
| 138 | MP0008004_abnormal_stomach_pH | 0.79606559 |
| 139 | MP0009931_abnormal_skin_appearance | 0.78830598 |
| 140 | MP0009764_decreased_sensitivity_to | 0.78756876 |
| 141 | MP0003705_abnormal_hypodermis_morpholog | 0.77942793 |
| 142 | MP0002876_abnormal_thyroid_physiology | 0.77801841 |
| 143 | MP0005503_abnormal_tendon_morphology | 0.76780866 |
| 144 | MP0010307_abnormal_tumor_latency | 0.76443289 |
| 145 | MP0005332_abnormal_amino_acid | 0.76052991 |
| 146 | MP0005165_increased_susceptibility_to | 0.74623462 |
| 147 | MP0003941_abnormal_skin_development | 0.73890603 |
| 148 | MP0000249_abnormal_blood_vessel | 0.73554231 |
| 149 | MP0003077_abnormal_cell_cycle | 0.73191564 |
| 150 | MP0004147_increased_porphyrin_level | 0.72982419 |
| 151 | MP0002693_abnormal_pancreas_physiology | 0.72897063 |
| 152 | MP0004510_myositis | 0.72188485 |
| 153 | MP0005636_abnormal_mineral_homeostasis | 0.72142927 |
| 154 | MP0009763_increased_sensitivity_to | 0.71991546 |
| 155 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.71070989 |
| 156 | MP0005076_abnormal_cell_differentiation | 0.70422021 |
| 157 | MP0002132_abnormal_respiratory_system | 0.70312904 |
| 158 | MP0008873_increased_physiological_sensi | 0.70178360 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 4.51080630 |
| 2 | Premature rupture of membranes (HP:0001788) | 4.48876176 |
| 3 | Thrombocytosis (HP:0001894) | 4.24954005 |
| 4 | Protrusio acetabuli (HP:0003179) | 4.23824077 |
| 5 | Deep venous thrombosis (HP:0002625) | 4.03448674 |
| 6 | Vertebral compression fractures (HP:0002953) | 3.93073950 |
| 7 | Chronic otitis media (HP:0000389) | 3.82672376 |
| 8 | IgM deficiency (HP:0002850) | 3.81518172 |
| 9 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.79615871 |
| 10 | Petechiae (HP:0000967) | 3.71091047 |
| 11 | Eczematoid dermatitis (HP:0000976) | 3.53767377 |
| 12 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.52260142 |
| 13 | Abnormality of complement system (HP:0005339) | 3.49974679 |
| 14 | Abnormality of T cell physiology (HP:0011840) | 3.48617759 |
| 15 | Systemic lupus erythematosus (HP:0002725) | 3.48353072 |
| 16 | Recurrent abscess formation (HP:0002722) | 3.44725090 |
| 17 | Myositis (HP:0100614) | 3.39362857 |
| 18 | Complement deficiency (HP:0004431) | 3.37183670 |
| 19 | Recurrent viral infections (HP:0004429) | 3.29747333 |
| 20 | Recurrent bacterial skin infections (HP:0005406) | 3.18859436 |
| 21 | Abnormality of glutamine family amino acid metabolism (HP:0010902) | 3.17871508 |
| 22 | Atrophic scars (HP:0001075) | 3.16916036 |
| 23 | Cervical subluxation (HP:0003308) | 3.14417470 |
| 24 | Interstitial pulmonary disease (HP:0006530) | 3.14313175 |
| 25 | Pustule (HP:0200039) | 3.08745151 |
| 26 | Recurrent fungal infections (HP:0002841) | 3.08321460 |
| 27 | Nasal polyposis (HP:0100582) | 3.06279681 |
| 28 | Abnormality of T cells (HP:0002843) | 3.06159147 |
| 29 | Abnormal number of erythroid precursors (HP:0012131) | 2.98245557 |
| 30 | Gastrointestinal inflammation (HP:0004386) | 2.97952584 |
| 31 | Hemorrhage of the eye (HP:0011885) | 2.92548681 |
| 32 | Inflammation of the large intestine (HP:0002037) | 2.91640081 |
| 33 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.90908110 |
| 34 | Upper limb amyotrophy (HP:0009129) | 2.90602824 |
| 35 | Distal upper limb amyotrophy (HP:0007149) | 2.90602824 |
| 36 | Prolonged bleeding time (HP:0003010) | 2.85323692 |
| 37 | Abnormality of the nasal mucosa (HP:0000433) | 2.82789449 |
| 38 | Reduced antithrombin III activity (HP:0001976) | 2.81147860 |
| 39 | Recurrent bronchitis (HP:0002837) | 2.81122561 |
| 40 | Epistaxis (HP:0000421) | 2.79693493 |
| 41 | Flat acetabular roof (HP:0003180) | 2.77347299 |
| 42 | Autoimmune thrombocytopenia (HP:0001973) | 2.76313408 |
| 43 | Aplastic anemia (HP:0001915) | 2.75760172 |
| 44 | Vacuolated lymphocytes (HP:0001922) | 2.75081474 |
| 45 | Impaired platelet aggregation (HP:0003540) | 2.73909375 |
| 46 | Abnormal platelet function (HP:0011869) | 2.73909375 |
| 47 | Glomerulonephritis (HP:0000099) | 2.63959707 |
| 48 | Cellulitis (HP:0100658) | 2.63933842 |
| 49 | Vascular tortuosity (HP:0004948) | 2.60778530 |
| 50 | Malnutrition (HP:0004395) | 2.60676732 |
| 51 | Fragile skin (HP:0001030) | 2.59746589 |
| 52 | Abnormality of the Achilles tendon (HP:0005109) | 2.59129457 |
| 53 | Ankle contracture (HP:0006466) | 2.58663410 |
| 54 | Meningitis (HP:0001287) | 2.57923301 |
| 55 | Xanthomatosis (HP:0000991) | 2.56414866 |
| 56 | Panhypogammaglobulinemia (HP:0003139) | 2.53132310 |
| 57 | Blue sclerae (HP:0000592) | 2.52476674 |
| 58 | Arterial tortuosity (HP:0005116) | 2.51699827 |
| 59 | Mucopolysacchariduria (HP:0008155) | 2.51698004 |
| 60 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.51698004 |
| 61 | Recurrent skin infections (HP:0001581) | 2.50444873 |
| 62 | T lymphocytopenia (HP:0005403) | 2.50315147 |
| 63 | Achilles tendon contracture (HP:0001771) | 2.49378824 |
| 64 | Colitis (HP:0002583) | 2.41062521 |
| 65 | Chest pain (HP:0100749) | 2.40580273 |
| 66 | Gingival bleeding (HP:0000225) | 2.38561857 |
| 67 | Hand muscle atrophy (HP:0009130) | 2.37046865 |
| 68 | Abnormal platelet volume (HP:0011876) | 2.36694364 |
| 69 | Spontaneous hematomas (HP:0007420) | 2.36612221 |
| 70 | Abnormality of T cell number (HP:0011839) | 2.36136419 |
| 71 | Aortic dissection (HP:0002647) | 2.35322295 |
| 72 | Dysostosis multiplex (HP:0000943) | 2.34736060 |
| 73 | Abnormality of carpal bone ossification (HP:0006257) | 2.33476305 |
| 74 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.28750879 |
| 75 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.28750879 |
| 76 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.28750879 |
| 77 | Cerebral aneurysm (HP:0004944) | 2.27609712 |
| 78 | Distal lower limb muscle weakness (HP:0009053) | 2.25651736 |
| 79 | Abnormality of the distal phalanges of the toes (HP:0010182) | 2.24432894 |
| 80 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.23015426 |
| 81 | Increased IgE level (HP:0003212) | 2.22295052 |
| 82 | Abnormal protein glycosylation (HP:0012346) | 2.21656085 |
| 83 | Abnormal glycosylation (HP:0012345) | 2.21656085 |
| 84 | Abnormal isoelectric focusing of serum transferrin (HP:0003160) | 2.21656085 |
| 85 | Abnormal protein N-linked glycosylation (HP:0012347) | 2.21656085 |
| 86 | Abnormality of macrophages (HP:0004311) | 2.19886522 |
| 87 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.19739765 |
| 88 | Cardiovascular calcification (HP:0011915) | 2.19652024 |
| 89 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.19542636 |
| 90 | Recurrent cutaneous fungal infections (HP:0011370) | 2.19542636 |
| 91 | Lymphopenia (HP:0001888) | 2.19218638 |
| 92 | Nephritis (HP:0000123) | 2.18688875 |
| 93 | Biconcave vertebral bodies (HP:0004586) | 2.17376173 |
| 94 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.17065136 |
| 95 | Wormian bones (HP:0002645) | 2.16691553 |
| 96 | Fatigue (HP:0012378) | 2.16093075 |
| 97 | Abnormal gallbladder physiology (HP:0012438) | 2.14999621 |
| 98 | Cholecystitis (HP:0001082) | 2.14999621 |
| 99 | Recurrent gram-negative bacterial infections (HP:0005420) | 2.14722552 |
| 100 | B lymphocytopenia (HP:0010976) | 2.14701528 |
| 101 | Abnormality of B cell number (HP:0010975) | 2.14701528 |
| 102 | Conjugated hyperbilirubinemia (HP:0002908) | 2.14503626 |
| 103 | Abnormality of glycolipid metabolism (HP:0010969) | 2.14499975 |
| 104 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.14499975 |
| 105 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.14499975 |
| 106 | Chronic diarrhea (HP:0002028) | 2.14163761 |
| 107 | Distal lower limb amyotrophy (HP:0008944) | 2.13516490 |
| 108 | Type I transferrin isoform profile (HP:0003642) | 2.10971948 |
| 109 | Agammaglobulinemia (HP:0004432) | 2.09945750 |
| 110 | Vascular calcification (HP:0004934) | 2.09263772 |
| 111 | Hydroxyprolinuria (HP:0003080) | 2.08403380 |
| 112 | Abnormality of proline metabolism (HP:0010907) | 2.08403380 |
| 113 | Increased connective tissue (HP:0009025) | 2.06249601 |
| 114 | Peritonitis (HP:0002586) | 2.05237866 |
| 115 | Abnormal ossification of hand bones (HP:0005921) | 2.05173887 |
| 116 | Osteolytic defects of the hand bones (HP:0009699) | 2.04485366 |
| 117 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.04485366 |
| 118 | J-shaped sella turcica (HP:0002680) | 2.03751785 |
| 119 | Increased mean platelet volume (HP:0011877) | 2.03171509 |
| 120 | Abnormality of pyrimidine metabolism (HP:0004353) | 2.02949890 |
| 121 | Disproportionate tall stature (HP:0001519) | 2.02535836 |
| 122 | Spinal rigidity (HP:0003306) | 2.02534324 |
| 123 | Thoracic kyphosis (HP:0002942) | 2.01754880 |
| 124 | Short nail (HP:0001799) | 2.01221186 |
| 125 | Hypertriglyceridemia (HP:0002155) | 2.01054121 |
| 126 | Verrucae (HP:0200043) | 1.98655464 |
| 127 | Papilloma (HP:0012740) | 1.98655464 |
| 128 | Genu recurvatum (HP:0002816) | 1.98640588 |
| 129 | Vasculitis (HP:0002633) | 1.98043348 |
| 130 | Dilatation of the ascending aorta (HP:0005111) | 1.97885758 |
| 131 | Hyperparathyroidism (HP:0000843) | 1.97860429 |
| 132 | Intrahepatic cholestasis (HP:0001406) | 1.97709594 |
| 133 | Elevated alkaline phosphatase (HP:0003155) | 1.97679317 |
| 134 | Loss of speech (HP:0002371) | 1.97390258 |
| 135 | Chronic obstructive pulmonary disease (HP:0006510) | 1.96138021 |
| 136 | Obstructive lung disease (HP:0006536) | 1.96138021 |
| 137 | Coxa vara (HP:0002812) | 1.95455500 |
| 138 | Purpura (HP:0000979) | 1.95206224 |
| 139 | Acanthosis nigricans (HP:0000956) | 1.93754580 |
| 140 | Back pain (HP:0003418) | 1.93508096 |
| 141 | Orchitis (HP:0100796) | 1.93493248 |
| 142 | Mitral stenosis (HP:0001718) | 1.93058366 |
| 143 | Menorrhagia (HP:0000132) | 1.91939116 |
| 144 | Hypobetalipoproteinemia (HP:0003563) | 1.91399222 |
| 145 | Abnormality of the acetabulum (HP:0003170) | 1.91113448 |
| 146 | Abnormality of the thoracic spine (HP:0100711) | 1.90607625 |
| 147 | Late onset (HP:0003584) | 1.89885152 |
| 148 | Abdominal distention (HP:0003270) | 1.89763307 |
| 149 | Bladder diverticulum (HP:0000015) | 1.89520673 |
| 150 | Stridor (HP:0010307) | 1.88809432 |
| 151 | Bone pain (HP:0002653) | 1.88636797 |
| 152 | Elbow flexion contracture (HP:0002987) | 1.87741761 |
| 153 | Aortic aneurysm (HP:0004942) | 1.87709779 |
| 154 | Hyperacusis (HP:0010780) | 1.87025636 |
| 155 | Increased variability in muscle fiber diameter (HP:0003557) | 1.85891582 |
| 156 | Abnormality of alkaline phosphatase activity (HP:0004379) | 1.85869276 |
| 157 | Hyperlipoproteinemia (HP:0010980) | 1.85683268 |
| 158 | Encephalitis (HP:0002383) | 1.84554732 |
| 159 | Amyloidosis (HP:0011034) | 1.84167332 |
| 160 | Nonimmune hydrops fetalis (HP:0001790) | 1.83654026 |
| 161 | Combined immunodeficiency (HP:0005387) | 1.83129429 |
| 162 | Aneurysm (HP:0002617) | 1.83087850 |
| 163 | Axonal loss (HP:0003447) | 1.82308955 |
| 164 | Urticaria (HP:0001025) | 1.82135013 |
| 165 | Skin ulcer (HP:0200042) | 1.81142042 |
| 166 | Osteomyelitis (HP:0002754) | 1.80490580 |
| 167 | Abnormal enzyme/coenzyme activity (HP:0012379) | 1.80357915 |
| 168 | Gingivitis (HP:0000230) | 1.79880615 |
| 169 | Generalized amyotrophy (HP:0003700) | 1.79506952 |
| 170 | Leukocytosis (HP:0001974) | 1.79505596 |
| 171 | Fat malabsorption (HP:0002630) | 1.79212969 |
| 172 | Polygenic inheritance (HP:0010982) | 1.78497925 |
| 173 | Poikiloderma (HP:0001029) | 1.78377744 |
| 174 | Hemoptysis (HP:0002105) | 1.78220833 |
| 175 | Joint hemorrhage (HP:0005261) | 1.77914912 |
| 176 | Abnormality of the prostate (HP:0008775) | 1.77769924 |
| 177 | Myocardial infarction (HP:0001658) | 1.77245983 |
| 178 | Granulocytopenia (HP:0001913) | 1.76800338 |
| 179 | Ulnar bowing (HP:0003031) | 1.76494407 |
| 180 | Joint stiffness (HP:0001387) | 1.76423788 |
| 181 | Gastrointestinal stroma tumor (HP:0100723) | 1.76217739 |
| 182 | Autoimmune hemolytic anemia (HP:0001890) | 1.76103078 |
| 183 | Abnormality of the fingertips (HP:0001211) | 1.73972031 |
| 184 | Arterial thrombosis (HP:0004420) | 1.73639773 |
| 185 | Increased serum ferritin (HP:0003281) | 1.73228683 |
| 186 | Hypergammaglobulinemia (HP:0010702) | 1.72685505 |
| 187 | Reticulocytopenia (HP:0001896) | 1.71823575 |
| 188 | Pulmonary infiltrates (HP:0002113) | 1.71422600 |
| 189 | Thin bony cortex (HP:0002753) | 1.71063355 |
| 190 | Hypoglycemic coma (HP:0001325) | 1.70963257 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MAP4K1 | 4.12177577 |
| 2 | ERN1 | 3.81582035 |
| 3 | EPHA2 | 3.50890442 |
| 4 | EEF2K | 3.36633013 |
| 5 | PRPF4B | 2.56006255 |
| 6 | TRIB3 | 2.41646641 |
| 7 | PKN2 | 2.39834994 |
| 8 | SMG1 | 2.39062888 |
| 9 | TAOK3 | 2.29660552 |
| 10 | ZAP70 | 2.27579343 |
| 11 | TYK2 | 2.18120458 |
| 12 | BLK | 2.10175870 |
| 13 | BTK | 2.05967960 |
| 14 | GRK6 | 1.99027922 |
| 15 | FLT3 | 1.98027428 |
| 16 | NME2 | 1.95023204 |
| 17 | STK10 | 1.92761097 |
| 18 | KIT | 1.89753658 |
| 19 | MAP3K10 | 1.79135844 |
| 20 | JAK3 | 1.78407540 |
| 21 | TEC | 1.77451903 |
| 22 | LRRK2 | 1.74062566 |
| 23 | ICK | 1.71060148 |
| 24 | SCYL2 | 1.69047059 |
| 25 | PTK2 | 1.68066632 |
| 26 | PDGFRA | 1.66919245 |
| 27 | TBK1 | 1.65691909 |
| 28 | MAP3K3 | 1.64726388 |
| 29 | TESK2 | 1.60297075 |
| 30 | EPHB2 | 1.54642978 |
| 31 | MET | 1.52447681 |
| 32 | TAOK2 | 1.47278786 |
| 33 | ARAF | 1.44856694 |
| 34 | TXK | 1.44114707 |
| 35 | DDR2 | 1.41139807 |
| 36 | PRKD2 | 1.39599486 |
| 37 | PIM2 | 1.38239149 |
| 38 | MAP2K3 | 1.36312385 |
| 39 | ITK | 1.35274586 |
| 40 | TESK1 | 1.34902530 |
| 41 | MYLK | 1.34381532 |
| 42 | CSF1R | 1.34042399 |
| 43 | SYK | 1.33399660 |
| 44 | IRAK4 | 1.32258279 |
| 45 | IKBKE | 1.30967591 |
| 46 | KDR | 1.27902320 |
| 47 | PTK6 | 1.26660369 |
| 48 | PAK4 | 1.21648047 |
| 49 | TGFBR2 | 1.19469963 |
| 50 | TTN | 1.17071280 |
| 51 | RPS6KB2 | 1.13785584 |
| 52 | CDC42BPA | 1.13717251 |
| 53 | PRKG2 | 1.13651517 |
| 54 | MST4 | 1.10791152 |
| 55 | MAPKAPK3 | 1.06653026 |
| 56 | RPS6KA4 | 1.06505299 |
| 57 | EPHB1 | 1.04769057 |
| 58 | PASK | 1.00584645 |
| 59 | CSK | 0.99767684 |
| 60 | MAP3K11 | 0.99398955 |
| 61 | MATK | 0.99171720 |
| 62 | FGFR4 | 0.97737239 |
| 63 | LCK | 0.95566335 |
| 64 | JAK1 | 0.94519198 |
| 65 | RIPK4 | 0.94423702 |
| 66 | FES | 0.94377433 |
| 67 | WNK3 | 0.93723664 |
| 68 | LIMK1 | 0.93718032 |
| 69 | PDPK1 | 0.93035317 |
| 70 | STK38 | 0.91207374 |
| 71 | MAP2K2 | 0.84736376 |
| 72 | PIM1 | 0.84510290 |
| 73 | PIK3CG | 0.83790406 |
| 74 | HCK | 0.82856951 |
| 75 | TGFBR1 | 0.82565934 |
| 76 | LATS2 | 0.81518860 |
| 77 | ABL2 | 0.80794471 |
| 78 | MAP3K8 | 0.80729484 |
| 79 | LYN | 0.80350544 |
| 80 | KSR2 | 0.77797548 |
| 81 | MTOR | 0.77353498 |
| 82 | SIK3 | 0.75781505 |
| 83 | MAPK11 | 0.75729400 |
| 84 | NTRK1 | 0.72953444 |
| 85 | JAK2 | 0.72260031 |
| 86 | HIPK2 | 0.72052422 |
| 87 | TAOK1 | 0.71859026 |
| 88 | CDK4 | 0.71312048 |
| 89 | NLK | 0.69895979 |
| 90 | MAP3K7 | 0.67833441 |
| 91 | IKBKB | 0.67793056 |
| 92 | MAP2K6 | 0.67568114 |
| 93 | IRAK3 | 0.66053752 |
| 94 | PRKD3 | 0.65945284 |
| 95 | MAP3K2 | 0.64989127 |
| 96 | EIF2AK3 | 0.64982490 |
| 97 | BCKDK | 0.64683485 |
| 98 | NEK9 | 0.62891776 |
| 99 | CDK6 | 0.61682562 |
| 100 | NEK2 | 0.60690538 |
| 101 | RIPK1 | 0.59040633 |
| 102 | MUSK | 0.58435241 |
| 103 | MAP3K12 | 0.58270213 |
| 104 | MST1R | 0.57536176 |
| 105 | MAP3K1 | 0.56712099 |
| 106 | LMTK2 | 0.54205225 |
| 107 | FRK | 0.53745834 |
| 108 | SIK1 | 0.53160073 |
| 109 | ILK | 0.51110239 |
| 110 | RPS6KA6 | 0.50521718 |
| 111 | STK16 | 0.50448219 |
| 112 | MAP3K14 | 0.48731660 |
| 113 | MAP2K1 | 0.48040778 |
| 114 | MARK2 | 0.47907516 |
| 115 | ACVR1B | 0.47317596 |
| 116 | CDK19 | 0.46775931 |
| 117 | MAPKAPK2 | 0.46680815 |
| 118 | MAPK4 | 0.46275654 |
| 119 | PAK2 | 0.46115735 |
| 120 | EPHA3 | 0.44845862 |
| 121 | BMX | 0.44110088 |
| 122 | PIK3CA | 0.42643415 |
| 123 | BRSK2 | 0.42484942 |
| 124 | CHUK | 0.42124879 |
| 125 | PRKCI | 0.41975394 |
| 126 | RPS6KC1 | 0.40200930 |
| 127 | RPS6KL1 | 0.40200930 |
| 128 | CDK7 | 0.40122084 |
| 129 | BRAF | 0.39937619 |
| 130 | CLK1 | 0.39675842 |
| 131 | PDGFRB | 0.39235058 |
| 132 | MAP3K13 | 0.38498788 |
| 133 | DYRK1B | 0.38459593 |
| 134 | MAP3K6 | 0.38155028 |
| 135 | MAPK7 | 0.37981267 |
| 136 | RET | 0.37414903 |
| 137 | CDK12 | 0.36810362 |
| 138 | RPS6KA2 | 0.36710561 |
| 139 | PDK1 | 0.36111846 |
| 140 | TRPM7 | 0.35782478 |
| 141 | WEE1 | 0.35284482 |
| 142 | SRC | 0.34895111 |
| 143 | PAK1 | 0.34523393 |
| 144 | MOS | 0.32670997 |
| 145 | ROCK2 | 0.32135167 |
| 146 | DAPK3 | 0.31740247 |
| 147 | LATS1 | 0.31523529 |
| 148 | CAMK2G | 0.27794587 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 2.71912916 |
| 2 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 2.50412243 |
| 3 | DNA replication_Homo sapiens_hsa03030 | 2.38588477 |
| 4 | Leishmaniasis_Homo sapiens_hsa05140 | 2.22294072 |
| 5 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 2.15502563 |
| 6 | Arginine biosynthesis_Homo sapiens_hsa00220 | 2.12165927 |
| 7 | Ribosome_Homo sapiens_hsa03010 | 2.09671308 |
| 8 | Antigen processing and presentation_Homo sapiens_hsa04612 | 2.05196674 |
| 9 | Other glycan degradation_Homo sapiens_hsa00511 | 2.03071986 |
| 10 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.87413515 |
| 11 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.80558197 |
| 12 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 1.78589860 |
| 13 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.78331446 |
| 14 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.75278300 |
| 15 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.74029624 |
| 16 | Retinol metabolism_Homo sapiens_hsa00830 | 1.73703761 |
| 17 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.67191350 |
| 18 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.63064307 |
| 19 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.62833700 |
| 20 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.59497133 |
| 21 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.58934743 |
| 22 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 1.58772713 |
| 23 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.57183760 |
| 24 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.55960770 |
| 25 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.54831779 |
| 26 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.53685581 |
| 27 | Prion diseases_Homo sapiens_hsa05020 | 1.52201610 |
| 28 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.51157710 |
| 29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.49393766 |
| 30 | Measles_Homo sapiens_hsa05162 | 1.47263962 |
| 31 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.45132501 |
| 32 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.42943869 |
| 33 | Sulfur relay system_Homo sapiens_hsa04122 | 1.42242040 |
| 34 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.41316856 |
| 35 | Galactose metabolism_Homo sapiens_hsa00052 | 1.40314619 |
| 36 | Bile secretion_Homo sapiens_hsa04976 | 1.40195072 |
| 37 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.36102266 |
| 38 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.34101282 |
| 39 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.33761324 |
| 40 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.33554823 |
| 41 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 1.33282838 |
| 42 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.32381279 |
| 43 | Legionellosis_Homo sapiens_hsa05134 | 1.32280374 |
| 44 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.30623073 |
| 45 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.30035217 |
| 46 | Mismatch repair_Homo sapiens_hsa03430 | 1.28918211 |
| 47 | Renin-angiotensin system_Homo sapiens_hsa04614 | 1.28709927 |
| 48 | Protein export_Homo sapiens_hsa03060 | 1.27988677 |
| 49 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.23968704 |
| 50 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22139977 |
| 51 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 1.22004229 |
| 52 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.19549347 |
| 53 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.19074861 |
| 54 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.17375562 |
| 55 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16780074 |
| 56 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.16645059 |
| 57 | Shigellosis_Homo sapiens_hsa05131 | 1.16233730 |
| 58 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.14443441 |
| 59 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.13292432 |
| 60 | Pertussis_Homo sapiens_hsa05133 | 1.13174522 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.11883196 |
| 62 | Selenocompound metabolism_Homo sapiens_hsa00450 | 1.09720234 |
| 63 | Base excision repair_Homo sapiens_hsa03410 | 1.09645078 |
| 64 | Protein digestion and absorption_Homo sapiens_hsa04974 | 1.09151824 |
| 65 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.08620495 |
| 66 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 1.06381020 |
| 67 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.05942432 |
| 68 | Amoebiasis_Homo sapiens_hsa05146 | 1.05528501 |
| 69 | Apoptosis_Homo sapiens_hsa04210 | 1.04321717 |
| 70 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 1.03168788 |
| 71 | Influenza A_Homo sapiens_hsa05164 | 1.03020242 |
| 72 | Hepatitis B_Homo sapiens_hsa05161 | 1.02349591 |
| 73 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 1.01808141 |
| 74 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.99586670 |
| 75 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.97943004 |
| 76 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.97629910 |
| 77 | Platelet activation_Homo sapiens_hsa04611 | 0.95206563 |
| 78 | Bladder cancer_Homo sapiens_hsa05219 | 0.94143427 |
| 79 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.93966852 |
| 80 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.93733752 |
| 81 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.92820576 |
| 82 | Thyroid cancer_Homo sapiens_hsa05216 | 0.91452344 |
| 83 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.91390668 |
| 84 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 0.90026993 |
| 85 | Tuberculosis_Homo sapiens_hsa05152 | 0.88809439 |
| 86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.88368067 |
| 87 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.87377418 |
| 88 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.87090865 |
| 89 | Focal adhesion_Homo sapiens_hsa04510 | 0.87090765 |
| 90 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.86147777 |
| 91 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.86119072 |
| 92 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.85480319 |
| 93 | Lysosome_Homo sapiens_hsa04142 | 0.81814694 |
| 94 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.81029465 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.80400851 |
| 96 | Hepatitis C_Homo sapiens_hsa05160 | 0.80301155 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.79385533 |
| 98 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.77086249 |
| 99 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.76787211 |
| 100 | Glutathione metabolism_Homo sapiens_hsa00480 | 0.74769472 |
| 101 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.70806278 |
| 102 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.70473967 |
| 103 | Histidine metabolism_Homo sapiens_hsa00340 | 0.68729376 |
| 104 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.67992711 |
| 105 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.67869359 |
| 106 | ABC transporters_Homo sapiens_hsa02010 | 0.67853906 |
| 107 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.66676537 |
| 108 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.63718397 |
| 109 | Aminoacyl-tRNA biosynthesis_Homo sapiens_hsa00970 | 0.62308497 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.61585771 |
| 111 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.60128513 |
| 112 | Carbon metabolism_Homo sapiens_hsa01200 | 0.59430475 |
| 113 | Mineral absorption_Homo sapiens_hsa04978 | 0.58995926 |
| 114 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.58177585 |
| 115 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.58156430 |
| 116 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.57956927 |
| 117 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.57757759 |
| 118 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.57588320 |
| 119 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.56777885 |
| 120 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.55621999 |
| 121 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.55271325 |
| 122 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.55215858 |
| 123 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.53734002 |
| 124 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.53544598 |
| 125 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.52606839 |
| 126 | Endocytosis_Homo sapiens_hsa04144 | 0.52395261 |
| 127 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.51708949 |
| 128 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.51241694 |
| 129 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.51021694 |
| 130 | Insulin resistance_Homo sapiens_hsa04931 | 0.49537645 |
| 131 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.49306869 |
| 132 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47927677 |
| 133 | Viral myocarditis_Homo sapiens_hsa05416 | 0.47129871 |
| 134 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.47030356 |
| 135 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47000531 |
| 136 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.46472558 |
| 137 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.45245829 |
| 138 | Endometrial cancer_Homo sapiens_hsa05213 | 0.44886701 |
| 139 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.43177940 |
| 140 | Homologous recombination_Homo sapiens_hsa03440 | 0.41109271 |
| 141 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.39616902 |
| 142 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.39370906 |
| 143 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.39244705 |
| 144 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.39015291 |
| 145 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.38687026 |
| 146 | Peroxisome_Homo sapiens_hsa04146 | 0.33391377 |
| 147 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.31785275 |

